Cas:1119898-47-3 (5E)-5-[[4-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)quinolin-6-yl]methylidene]-1,3-thiazolidine-2,4-dione manufacturer & supplier

We serve Chemical Name:(5E)-5-[[4-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)quinolin-6-yl]methylidene]-1,3-thiazolidine-2,4-dione CAS:1119898-47-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(5E)-5-[[4-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)quinolin-6-yl]methylidene]-1,3-thiazolidine-2,4-dione

Chemical Name:(5E)-5-[[4-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)quinolin-6-yl]methylidene]-1,3-thiazolidine-2,4-dione
CAS.NO:1119898-47-3
Synonyms:(5E)-5-[[4-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)quinolin-6-yl]methylidene]-1,3-thiazolidine-2,4-dione
Molecular Formula:C19H12N2O4S2
Molecular Weight:396.44000
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:134.55000
Exact Mass:396.02400
LogP:4.33430

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (5E)-5-[[4-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)quinolin-6-yl]methylidene]-1,3-thiazolidine-2,4-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(5E)-5-[[4-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)quinolin-6-yl]methylidene]-1,3-thiazolidine-2,4-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(5E)-5-[[4-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)quinolin-6-yl]methylidene]-1,3-thiazolidine-2,4-dione Use and application,(5E)-5-[[4-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)quinolin-6-yl]methylidene]-1,3-thiazolidine-2,4-dione technical grade,usp/ep/jp grade.


Related News: The pivotal TULIP (Treatment of Uncontrolled Lupus via the Interferon Pathway) phase III programme includes two trials, TULIP-1 and TULIP-2, that evaluated the efficacy and safety of anifrolumab versus placebo. (4-Chlorophenyl)(1-{2-[(3-nitrobenzyl)amino]ethyl}-4-piperidinyl)methanone manufacturers MG is a “serious, lifelong disease with life-threatening manifestations, and most patients do not achieve treatment goals with conventional therapy,” the report said. 3-acetylthio-3-(4-phenoxybenzoyl)propionic acid suppliers Type I interferons such as IFN-alpha, IFN-beta and IFN-kappa are cytokines involved in regulating the inflammatory pathways implicated in lupus. 1,1′-(1,3-propanediyl)bis[5-(3-(4-methylbenzenesulfonyloxy)propyl)-2-methoxybenzene] vendor & factory.